oligometastatic incidence and prognosis. ASCO 2012

jenrio

Coming up in ASCO 2012.   Some very encouraging survival information for the <=5 mets folks (at the time of first treatment failure).   Not so encouraging for the >5 mets patients at the 1st treatment failure.   So don't read it if you fit the latter criteria.    If you really want to read it anyway, remember the data is old.

 

http://abstract.asco.org/AbstView_114_100353.html

 

This division of oligo and poly, division of TN from HR+ or HER+ BC patients, is why I hate BC so much.   I wish there's a cure for all but every step to the cure must be made in baby steps.   So now, 20 years later, MBC survival is still measured in months, while AIDS survival is near normal life span, Parkinson is close to a cure, etc. etc.